was read the article
array:20 [ "pii" => "X2013251412001708" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2012.Jun.11538" "estado" => "S300" "fechaPublicacion" => "2012-09-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2012;32:699-700" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4491 "formatos" => array:3 [ "EPUB" => 311 "HTML" => 3682 "PDF" => 498 ] ] "Traduccion" => array:1 [ "es" => array:17 [ "pii" => "X0211699512001700" "issn" => "02116995" "doi" => "10.3265/Nefrologia.pre2012.Jun.11538" "estado" => "S300" "fechaPublicacion" => "2012-09-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2012;32:699-700" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 6672 "formatos" => array:3 [ "EPUB" => 288 "HTML" => 5802 "PDF" => 582 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Amiloidosis renal AA en un paciente con enfermedad de Castleman" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "699" "paginaFinal" => "700" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Renal AA amyloidosis in a Castleman¿s disease patient" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "11538_108_31318_es_11538_f1.jpg" "Alto" => 653 "Ancho" => 600 "Tamanyo" => 335315 ] ] "descripcion" => array:1 [ "es" => "Glomérulos con depósito de material amorfo y rojizo. Rojo Congo" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Teresa Caro-Cuenca, Rosa Ortega-Salas, Mario Espinosa-Hernández" "autores" => array:3 [ 0 => array:2 [ "nombre" => "M. Teresa" "apellidos" => "Caro-Cuenca" ] 1 => array:2 [ "nombre" => "Rosa" "apellidos" => "Ortega-Salas" ] 2 => array:2 [ "nombre" => "Mario" "apellidos" => "Espinosa-Hernández" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "X2013251412001708" "doi" => "10.3265/Nefrologia.pre2012.Jun.11538" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251412001708?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699512001700?idApp=UINPBA000064" "url" => "/02116995/0000003200000005/v0_201502091343/X0211699512001700/v0_201502091344/es/main.assets" ] ] "itemAnterior" => array:17 [ "pii" => "X2013251412001716" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2012.Jun.11563" "estado" => "S300" "fechaPublicacion" => "2012-09-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2012;32:697-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4948 "formatos" => array:3 [ "EPUB" => 286 "HTML" => 4206 "PDF" => 456 ] ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "Cutaneous cryptococcosis in a patient on chronic haemodialysis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "697" "paginaFinal" => "698" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Criptococosis cutánea en un paciente que recibe hemodiálisis crónica" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "11563_16025_35719_en_f111563.jpg" "Alto" => 583 "Ancho" => 1389 "Tamanyo" => 406517 ] ] "descripcion" => array:1 [ "en" => "Evolution of lesions" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Gera A. Latino, Emilio Gago, Pedro Vidau, Blanca Vivanco" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Gera A." "apellidos" => "Latino" ] 1 => array:2 [ "nombre" => "Emilio" "apellidos" => "Gago" ] 2 => array:2 [ "nombre" => "Pedro" "apellidos" => "Vidau" ] 3 => array:2 [ "nombre" => "Blanca" "apellidos" => "Vivanco" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X0211699512001719" "doi" => "10.3265/Nefrologia.pre2012.Jun.11563" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699512001719?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251412001716?idApp=UINPBA000064" "url" => "/20132514/0000003200000005/v0_201502091606/X2013251412001716/v0_201502091607/en/main.assets" ] "en" => array:12 [ "idiomaDefecto" => true "titulo" => "Renal AA amyloidosis in a Castleman's disease patient" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "699" "paginaFinal" => "700" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "M. Teresa Caro-Cuenca, Rosa Ortega-Salas, Mario Espinosa-Hernández" "autores" => array:3 [ 0 => array:3 [ "nombre" => "M. Teresa" "apellidos" => "Caro-Cuenca" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 1 => array:3 [ "nombre" => "Rosa" "apellidos" => "Ortega-Salas" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 2 => array:4 [ "nombre" => "Mario" "apellidos" => "Espinosa-Hernández" "email" => array:1 [ 0 => "espinosahe@ono.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Anatomía Patológica, Hospital Universitario Reina Sofía, Córdoba, " "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] 1 => array:3 [ "entidad" => "Nefrología, Hospital Universitario Reina Sofía, Córdoba, " "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Amiloidosis renal AA en un paciente con enfermedad de Castleman" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "11538_16025_35724_en_f111538.jpg" "Alto" => 713 "Ancho" => 654 "Tamanyo" => 364899 ] ] "descripcion" => array:1 [ "en" => "Glomeruli with deposits of an amorphous red material. Congo red stain" ] ] ] "textoCompleto" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">To the Editor: </span></p><p class="elsevierStylePara">Castleman’s disease is a benign lymphoproliferative disease that develops in the form of lymphoid follicular hyperplasia in which renal involvement is uncommon. Only isolated case reports and small series (20 patients) have been reported. The two most common types of lesions reported in these cases are thrombotic microangiopathy-like (TMA-like) and AA amyloidosis.<span class="elsevierStyleSup">1-4</span></p><p class="elsevierStylePara">Here, we present the case of a 30-year-old male with a history of thalassemia minor and who was diagnosed with nephrotic syndrome and normal renal function. A renal biopsy revealed a mesangial deposit of an amorphous eosinophilic material prone to form nodules, which was dispersed uniformly throughout the glomeruli and in small vessel walls. This material was Congo red positive, with birefringence in polarised light and immunohistochemical expression for amyloid A. Staining with vascular endothelial growth factor (VEGF) and synaptopodin was intensely expressed in the podocytes (Figure 1). The diagnosis was made of type AA renal amyloidosis with a glomerular/vascular distribution. Serology for human immunodeficiency virus (HIV) was negative, and an immunological analysis ruled out the possibility of systemic or infectious disease.</p><p class="elsevierStylePara">An abdominal/pelvic computerised axial tomography revealed a solid and heterogeneous mass of 9.5cm in diameter and with calcifications that was in contact with the small intestine. The resected section of the small intestine had a fleshy mesenteric tumour with no relation to the intestinal wall. Histological analysis revealed that the tumour was an adenopathic mass with preserved structure and lymphoid follicular hyperplasia, with a heterogeneous appearance (Figure 2); the paracortical region contained a diffuse proliferation of mature plasma cells, with no atypia and abundant Russell bodies. Serology for herpesvirus 8 (HHV8) was negative.</p><p class="elsevierStylePara">In this case, the histopathological diagnosis was plasma cell-type Castleman’s disease. We also identified amyloid deposits in the perivascular region, the paracortex, and the submucosa of the small intestine.</p><p class="elsevierStylePara">The final diagnosis for our patient was systemic AA amyloidosis associated with Castleman’s disease, plasma cell type.</p><p class="elsevierStylePara"> </p><p class="elsevierStylePara"><span class="elsevierStyleBold">DISCUSSION </span></p><p class="elsevierStylePara"> </p><p class="elsevierStylePara">Castleman’s disease is an uncommon and benign lymphoproliferative disease that presents in the form of lymphoid follicular hyperplasia. In some cases it is associated with HIV or HHV8.<span class="elsevierStyleSup">5</span> It has also been correlated with malignant diseases such as Kaposi’s sarcoma and certain lymphomas. Two distinct entities have been described: localised and multi-centric, which are very different in terms of prognosis. Classically, two different histological types have also been identified: hyaline-vascular and plasma cell. The localised hyaline-vascular type is the most common (80%); it is asymptomatic and tends to have a benign prognosis. The plasma cell type is associated with a more aggressive clinical progression and the presence of constitutional syndrome. In contrast to the hyaline-vascular type, multi-centric plasma cell type may be associated with infection by HHV8, above all in patients with HIV. Renal involvement in Castleman’s disease is uncommon, but the most commonly described forms are thrombotic microangiopathic-like (TMA-like) and AA amyloidosis. The prognosis for the renal damage, once the cause is corrected, appears to be based on the extent and intensity of the glomerular deposits as well as the vascular damage produced. We are unaware of the reason why certain patients develop vascular lesions while others develop amyloidosis. Some authors have suggested that the vascular lesion is mediated by a decreasing regulation of VEGF that is produced in these lymphoproliferative diseases.<span class="elsevierStyleSup">1</span> In our patient, the conserved expression of both VEGF and synaptopodin, a crucial protein in the maintenance of the glomerular filtration barrier, could be indicators for a good prognosis, with potentially reversible proteinuria.</p><p class="elsevierStylePara">The cases that progress with amyloidosis AA tend to occur in patients with localised abdominal Castleman’s disease, as occurred in our case: long-term chronic inflammatory syndrome could contribute to the development of amyloidosis. It is also believed to be mediated by high levels of interleukin 6.<span class="elsevierStyleSup">6-7</span></p><p class="elsevierStylePara">In a young patient with AA renal amyloidosis and no other possible diagnosis, plasma cell-type Castleman’s disease may be considered the cause. A study of VEGF or synaptopodin expression can contribute to evaluating and establishing a prognosis for renal lessions.</p><p class="elsevierStylePara"> </p><p class="elsevierStylePara"><span class="elsevierStyleBold">Conflicts of interest</span></p><p class="elsevierStylePara"> </p><p class="elsevierStylePara">The authors have no conflicts of interest to declare.</p><p class="elsevierStylePara"><a href="grande/11538_16025_35724_en_f111538.jpg" class="elsevierStyleCrossRefs"><img src="11538_16025_35724_en_f111538.jpg" alt="Glomeruli with deposits of an amorphous red material. Congo red stain"></img></a></p><p class="elsevierStylePara">Figure 1. Glomeruli with deposits of an amorphous red material. Congo red stain</p><p class="elsevierStylePara"><a href="grande/11538_16025_35725_en_f211538.jpg" class="elsevierStyleCrossRefs"><img src="11538_16025_35725_en_f211538.jpg" alt="Adenopathic mass with heterogeneous lymphoid follicular hyperplasia and preserved structure. H-E 20x"></img></a></p><p class="elsevierStylePara">Figure 2. Adenopathic mass with heterogeneous lymphoid follicular hyperplasia and preserved structure. H-E 20x</p>" "pdfFichero" => "P1-E543-S3700-A11538-EN.pdf" "tienePdf" => true "multimedia" => array:2 [ 0 => array:8 [ "identificador" => "fig1" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "11538_16025_35724_en_f111538.jpg" "Alto" => 713 "Ancho" => 654 "Tamanyo" => 364899 ] ] "descripcion" => array:1 [ "en" => "Glomeruli with deposits of an amorphous red material. Congo red stain" ] ] 1 => array:8 [ "identificador" => "fig2" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "11538_16025_35725_en_f211538.jpg" "Alto" => 887 "Ancho" => 653 "Tamanyo" => 323999 ] ] "descripcion" => array:1 [ "en" => "Adenopathic mass with heterogeneous lymphoid follicular hyperplasia and preserved structure. H-E 20x" ] ] ] "bibliografia" => array:2 [ "titulo" => "Bibliography" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:7 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "El Karoui K, Vuiblet V, Dion D, Izzedine H, Guitard J, Frimat L, et al.\u{A0}Renal involvement in Castleman disease. Nephrol Dial Transplant 2011;26:599-609. <a href="http://www.ncbi.nlm.nih.gov/pubmed/20656751" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "2.\u{A0}Bestard Matamoros O,\u{A0}Poveda Monje R,\u{A0}Ibernon Vilaró M,\u{A0}Carrera Plans M,\u{A0}Grinyó Boira JM. Amiloidosis secundaria (AA) asociada a tumoraciones benignas. Nefrologia 2008;28:93-8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18336138" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Arinsoy T, Yilmaz M, Atao lu Ö, Bali M, Sindel S. Castleman¿s disease with renal amyloidosis and nephrotic syndrome. Nephrol Dial Transplant 1997;12:2713-6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9430878" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Perfetti V, Bellotti V, Maggi A,\u{A0}Arbustini E, De Benedetti F, Paulli M, et al. Reversal of nephrotic syndrome due to reactive amyloidosis after excision of localized Castleman¿s disease. Am J Hematol 1994;46:189-93. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7910717" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Aaron L, Lidove O, Yousry C, Roudiere L, Dupont B, Viard JP. Human herpesvirus 8-positive Castleman disease in human immunodeficiency virus-infected patients: the impact of highly active antiretroviral therapy. Clin Infect Dis 2002;35:880-2. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12228826" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Ikeda S, Chisuwa H, Kawasaki S, Ozawa J, Hoshii Y, Yokota T, et al. Systemic reactive amyloidosis associated with Castleman¿s disease: serial changes of the concentrations of acute phase amyloid A and interleukina 6 in serum.\u{A0}J Clin\u{A0}Pathol 1997;50:965-7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9462253" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Yoshizaki K, Matsuda T, Nishimoto N. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman¿s disease. Blood 1989;74:1360-7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/2788466" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/20132514/0000003200000005/v0_201502091606/X2013251412001708/v0_201502091607/en/main.assets" "Apartado" => array:4 [ "identificador" => "35437" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor - Brief Case Reports" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/20132514/0000003200000005/v0_201502091606/X2013251412001708/v0_201502091607/en/P1-E543-S3700-A11538-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251412001708?idApp=UINPBA000064" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 10 | 10 | 20 |
2024 October | 68 | 29 | 97 |
2024 September | 85 | 30 | 115 |
2024 August | 73 | 56 | 129 |
2024 July | 34 | 26 | 60 |
2024 June | 66 | 36 | 102 |
2024 May | 71 | 17 | 88 |
2024 April | 67 | 46 | 113 |
2024 March | 43 | 24 | 67 |
2024 February | 60 | 32 | 92 |
2024 January | 62 | 30 | 92 |
2023 December | 45 | 22 | 67 |
2023 November | 57 | 30 | 87 |
2023 October | 54 | 28 | 82 |
2023 September | 57 | 36 | 93 |
2023 August | 55 | 18 | 73 |
2023 July | 58 | 19 | 77 |
2023 June | 52 | 17 | 69 |
2023 May | 58 | 25 | 83 |
2023 April | 50 | 14 | 64 |
2023 March | 45 | 20 | 65 |
2023 February | 30 | 21 | 51 |
2023 January | 38 | 19 | 57 |
2022 December | 52 | 25 | 77 |
2022 November | 38 | 23 | 61 |
2022 October | 67 | 32 | 99 |
2022 September | 43 | 21 | 64 |
2022 August | 48 | 38 | 86 |
2022 July | 42 | 49 | 91 |
2022 June | 49 | 35 | 84 |
2022 May | 55 | 18 | 73 |
2022 April | 59 | 49 | 108 |
2022 March | 59 | 40 | 99 |
2022 February | 51 | 49 | 100 |
2022 January | 44 | 31 | 75 |
2021 December | 43 | 34 | 77 |
2021 November | 41 | 34 | 75 |
2021 October | 58 | 37 | 95 |
2021 September | 47 | 27 | 74 |
2021 August | 35 | 40 | 75 |
2021 July | 45 | 21 | 66 |
2021 June | 51 | 21 | 72 |
2021 May | 48 | 28 | 76 |
2021 April | 155 | 54 | 209 |
2021 March | 80 | 41 | 121 |
2021 February | 53 | 17 | 70 |
2021 January | 41 | 13 | 54 |
2020 December | 28 | 15 | 43 |
2020 November | 38 | 16 | 54 |
2020 October | 39 | 15 | 54 |
2020 September | 23 | 7 | 30 |
2020 August | 41 | 5 | 46 |
2020 July | 40 | 16 | 56 |
2020 June | 38 | 7 | 45 |
2020 May | 48 | 13 | 61 |
2020 April | 39 | 15 | 54 |
2020 March | 46 | 10 | 56 |
2020 February | 35 | 16 | 51 |
2020 January | 42 | 19 | 61 |
2019 December | 44 | 16 | 60 |
2019 November | 39 | 18 | 57 |
2019 October | 14 | 6 | 20 |
2019 September | 24 | 25 | 49 |
2019 August | 37 | 7 | 44 |
2019 July | 33 | 21 | 54 |
2019 June | 35 | 11 | 46 |
2019 May | 30 | 12 | 42 |
2019 April | 47 | 24 | 71 |
2019 March | 37 | 29 | 66 |
2019 February | 27 | 15 | 42 |
2019 January | 29 | 22 | 51 |
2018 December | 77 | 26 | 103 |
2018 November | 108 | 12 | 120 |
2018 October | 109 | 14 | 123 |
2018 September | 69 | 15 | 84 |
2018 August | 50 | 13 | 63 |
2018 July | 57 | 10 | 67 |
2018 June | 43 | 12 | 55 |
2018 May | 48 | 15 | 63 |
2018 April | 64 | 9 | 73 |
2018 March | 59 | 11 | 70 |
2018 February | 47 | 3 | 50 |
2018 January | 33 | 12 | 45 |
2017 December | 55 | 8 | 63 |
2017 November | 37 | 6 | 43 |
2017 October | 35 | 8 | 43 |
2017 September | 41 | 7 | 48 |
2017 August | 28 | 9 | 37 |
2017 July | 41 | 9 | 50 |
2017 June | 41 | 5 | 46 |
2017 May | 36 | 13 | 49 |
2017 April | 36 | 4 | 40 |
2017 March | 27 | 2 | 29 |
2017 February | 44 | 6 | 50 |
2017 January | 36 | 5 | 41 |
2016 December | 54 | 6 | 60 |
2016 November | 73 | 7 | 80 |
2016 October | 109 | 6 | 115 |
2016 September | 137 | 4 | 141 |
2016 August | 177 | 2 | 179 |
2016 July | 182 | 3 | 185 |
2016 June | 133 | 0 | 133 |
2016 May | 150 | 0 | 150 |
2016 April | 96 | 0 | 96 |
2016 March | 99 | 0 | 99 |
2016 February | 99 | 0 | 99 |
2016 January | 84 | 0 | 84 |
2015 December | 124 | 0 | 124 |
2015 November | 84 | 0 | 84 |
2015 October | 85 | 0 | 85 |
2015 September | 71 | 0 | 71 |
2015 August | 73 | 0 | 73 |
2015 July | 65 | 0 | 65 |
2015 June | 39 | 0 | 39 |
2015 May | 61 | 0 | 61 |
2015 April | 6 | 0 | 6 |